1. Home
  2. TRX vs LCTX Comparison

TRX vs LCTX Comparison

Compare TRX & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRX
  • LCTX
  • Stock Information
  • Founded
  • TRX 1990
  • LCTX 1990
  • Country
  • TRX Canada
  • LCTX United States
  • Employees
  • TRX N/A
  • LCTX N/A
  • Industry
  • TRX
  • LCTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TRX
  • LCTX Health Care
  • Exchange
  • TRX Nasdaq
  • LCTX Nasdaq
  • Market Cap
  • TRX 94.5M
  • LCTX 107.3M
  • IPO Year
  • TRX N/A
  • LCTX N/A
  • Fundamental
  • Price
  • TRX $0.34
  • LCTX $1.00
  • Analyst Decision
  • TRX Strong Buy
  • LCTX Strong Buy
  • Analyst Count
  • TRX 1
  • LCTX 5
  • Target Price
  • TRX $1.50
  • LCTX $4.20
  • AVG Volume (30 Days)
  • TRX 404.8K
  • LCTX 4.2M
  • Earning Date
  • TRX 07-22-2025
  • LCTX 08-07-2025
  • Dividend Yield
  • TRX N/A
  • LCTX N/A
  • EPS Growth
  • TRX N/A
  • LCTX N/A
  • EPS
  • TRX N/A
  • LCTX N/A
  • Revenue
  • TRX $45,405,000.00
  • LCTX $9,557,000.00
  • Revenue This Year
  • TRX $51.45
  • LCTX N/A
  • Revenue Next Year
  • TRX $26.19
  • LCTX $232.66
  • P/E Ratio
  • TRX N/A
  • LCTX N/A
  • Revenue Growth
  • TRX 26.50
  • LCTX 19.42
  • 52 Week Low
  • TRX $0.27
  • LCTX $0.37
  • 52 Week High
  • TRX $0.45
  • LCTX $1.15
  • Technical
  • Relative Strength Index (RSI)
  • TRX 54.18
  • LCTX 66.90
  • Support Level
  • TRX $0.33
  • LCTX $0.93
  • Resistance Level
  • TRX $0.35
  • LCTX $1.06
  • Average True Range (ATR)
  • TRX 0.01
  • LCTX 0.11
  • MACD
  • TRX -0.00
  • LCTX -0.00
  • Stochastic Oscillator
  • TRX 50.50
  • LCTX 70.00

About TRX TRX Gold Corporation

TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. It is focused on the Buckreef Gold Project which comprises five prospects, namely Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.

Share on Social Networks: